Overweight Clinical Trial
Official title:
Canadian Diabetes Strategy Research Project - HealtheSteps™: Exercise and Healthy Eating Prescriptions to Reduce the Risk of Diabetes in Rural and Remote Communities: A Pilot Pragmatic Randomized Controlled Trial (Project 3).
The HealtheSteps™ (HeS) Program is an evidence-based, community-focused, lifestyle prescription (Rx) program, supported by in-person coaching and innovative health technologies. The program improves the health of Canadians and reduces their risk for chronic disease by tackling three major risk factors that are shared across a number of chronic diseases: physical inactivity, sedentary behaviour and poor diet. Each HeS participant receives an individualized healthy living Rx for exercise, physical activity (step counts) and healthy eating, supported by coaching and technology tools to promote long-term health behaviour change. For this study, the investigators will undertake a 6-month pilot pragmatic randomized controlled trial (RCT), conducted within 5 clinic settings in Southwestern Ontario. The primary aim is to conduct an outcome evaluation to determine the effectiveness of the HeS program in helping at-risk individuals increase physical activity levels, improve eating habits, and improve other health behaviours and health indicators.
The HealtheSteps™ (HeS) program was developed to improve the health of Canadians and reduce
their risk for chronic disease (CD) and brings together emerging evidence from the areas of
physical activity, nutrition, behaviour change, health technologies, and knowledge transfer,
and moves knowledge into practice. HeS is an evidence-based, viable, and scalable healthy
lifestyle solution to tackle the epidemic of CD in Canada. HeS goes beyond traditional health
promotion messaging to give individuals a specific plan of action to improve their health and
provides community settings with hands-on training, and resources from study knowledge
brokers (KBs) to facilitate program uptake and sustainability. The investigators suggest that
a widely available HeS program has the potential to impact the lives of Canadians at-risk for
and living with CD; shift practice patterns within Family Health Teams (FHTs), Community
Health Centres (CHCs) and clinics; reduce health care costs associated with CD; and inform
policy decisions about health resource allocation and human resource planning. A scaled-up
HeS program will offer at-risk Canadians an opportunity to actively participate in an
evidence-based, community-focused, affordable (no cost to participant), healthy lifestyle
program supported by point-of-care coaching and innovative electronic Health (eHealth)
technologies.
This study will use a two-arm, pilot pragmatic randomized controlled trial (RCT) design. It
will take place within 5 clinic settings in Southwestern Ontario. Following assessment of
eligibility and baseline measurements, participants will be individually randomized (1:1;
stratified by clinical setting) to either the intervention group (receiving the HeS program)
or to the comparison group (usual care wait-list control). The comparison group will be
offered to start the HeS program after a 6 month delay. All participants (both intervention
and comparison groups) will receive publicly available healthy eating and physical activity
materials at baseline. Measurements will be taken at baseline and 6 months in both groups;
additional follow-up measurements will be taken in the intervention group only at 12 months
and again at 18 months (from baseline). Groups will be compared at 6-months in order to
examine effectiveness of the HeS program; further, follow-up to 12 and 18 months will be used
to look at maintenance of any changes in the intervention group only.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |